Lck-IN-3
Lck-IN-3 (compound 7m) is an LCK inhibitor that targets acute lymphoblastic leukemia (ALL) by inhibiting LCK phosphorylation. Lck-IN-3 can induce cell cycle arrest at the G2/M phase, leading to apoptosis in ALL cells.
Product Specifications
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Molecular Formula
C28H22N6O2S
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![N-[ (2'-Cyano[1,1'-biphenyl]-4-yl) methyl]-N- (1-oxopentyl) -L-valine Methyl Ester](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
457518-01 25 mg
N-[ (2'-Cyano[1,1'-biphenyl]-4-yl) methyl]-N- (1-oxopentyl) -L-valine Methyl Ester
Sign In for Pricing
View Details 457518-02 50 mg
N-[ (2'-Cyano[1,1'-biphenyl]-4-yl) methyl]-N- (1-oxopentyl) -L-valine Methyl Ester
Sign In for Pricing
View Details 
33569064 1.0 µg DNA
Olfr95 Lentiviral Vector (Mouse) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details